(Global Executive Moves is a news service brought to you by Kingsley Gate Partners. This should not to be construed as placements made by KGP.)
Private Equity Industry Banner
Mouse Scroll Icon
June 2023

Ensem Therapeutics Inc. announces Dr. Shengfang Jin as Chief Executive Officer

Ensem Therapeutics Inc. announced the promotion of Dr. Shengfang Jin to President and Chief Executive Officer, effective immediately.

Dr. Shengfang, a co-founder of Ensem Therapeutics, has over 25 years of leadership experience in biotech and pharma. Previously serving as the President and Chief Scientific Officer of the company, she played a pivotal role in its inception and growth. 

Ensem Therapeutics Inc. focuses on the development of an oncology portfolio targeting both established and novel therapeutic targets with significant unmet medical needs.